XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 4,372,805 $ 4,777,242 $ 11,233,235 $ 9,300,999
General and administrative 1,062,644 807,177 1,975,468 1,581,976
Total operating expenses 5,435,449 5,584,419 13,208,703 10,882,975
Loss from operations (5,435,449) (5,584,419) (13,208,703) (10,882,975)
Other income (expense):        
Change in estimated fair value of warrant liability (240,339) (50,194) (272,854) (45,090)
Loss on issuance of related party convertible notes payable at fair value (200,000) 0 (400,000) 0
Change in estimated fair value of related party convertible notes payable (700,000) 0 (1,000,000) 0
Interest expense (5,076) (5,062) (10,152) (33,516)
Interest income 8,645 115,389 23,431 167,040
Total other income (expense), net (1,136,770) 60,133 (1,659,575) 88,434
Net loss $ (6,572,219) $ (5,524,286) $ (14,868,278) $ (10,794,541)
Weighted-average shares of common stock outstanding, basic 1,565,777 1,422,164 1,550,456 1,381,734
Weighted-average shares of common stock outstanding, diluted 1,565,777 1,422,164 1,550,456 1,381,734